Company · CIK 0002130606 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Obsidian Therapeutics, Inc. · OBX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 AForm 4 → | Aug 5, 4:10 pm EDT | Robert W. RossDirector | 37,653 | — | — | 37,653 | — | |
| Aug 3, 2026 AForm 4 → | Aug 5, 4:08 pm EDT | Matthew NorkunasDirector | 37,653 | — | — | 37,653 | — | |
| Aug 3, 2026 AForm 4 → | Aug 5, 4:08 pm EDT | Madan JagasiaChief Executive Officer, Director | 37,653 | — | — | 37,653 | — | |
| Aug 3, 2026 AForm 4 → | Aug 5, 4:07 pm EDT | Peter BarrettDirector | 37,653 | — | — | 37,653 | — | |
| Aug 3, 2026 AForm 4 → | Aug 5, 4:06 pm EDT | Heidi HagenDirector | 37,653 | — | — | 37,653 | — | |
| Aug 3, 2026 AForm 4 → | Aug 5, 4:05 pm EDT | Maria FardisDirector | 37,653 | — | — | 37,653 | — |